Model-Based Dose Identification of Dalbavancin for Long-Term Suppressive Outpatient Treatment of Ventricular Assist Device Infections

Model-Based Dose Identification of Dalbavancin for Long-Term Suppressive Outpatient Treatment of Ventricular Assist Device Infections

Increasing evidence suggests that dalbavancin is an effective long-term treatment for ventricular assist device (VAD) infections, with various prolonged dosing regimens currently in use. This retrospective study aimed to assess dalbavancin pharmacokinetics in VAD patients and identify optimal, feasi...

Full description

Saved in:
Bibliographic Details
Main Authors: Ute Chiriac, Uwe Liebchen, Otto Roman Frey, Heike Lanzinger, Sabrina Klein, Torsten Hoppe-Tichy, Matthias Karck, Anna Meyer, Benedict Morath
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Antibiotics
Subjects:
dalbavancin
ventricular assist device
population pharmacokinetics
therapeutic drug monitoring
long-term treatment
Online Access:https://www.mdpi.com/2079-6382/13/11/1103
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2079-6382/13/11/1103

Similar Items